AudioScholar Pulmonary Weekly

AudioScholar

Pulmonary — a weekly podcast briefing of the most significant peer-reviewed pulmonary literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. 4d ago

    This Week in Pulmonary — Aug 11, 2026

    Welcome to This Week in Pulmonary. This week we're covering 10 notable papers spanning thoracic oncology and lung cancer screening, sleep-disordered breathing and cardiovascular risk, and a mixed bag of results in obstructive and interstitial lung di… This week's papers: 1. Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial. — JAMA 2026 2. Association of Positive airway pressure adherence with mortality and cardiovascular events in high vs low risk sleep apnoea patients. — European Respiratory Journal 2026 3. Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension. — European Respiratory Journal 2026 4. Health Communication and Stepped Reminders Interventions for Lung Cancer Screening: A Randomized Clinical Trial. — JAMA Internal Medicine 2026 5. A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonar… — European Respiratory Journal 2026 6. Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid. — Journal of Thoracic Oncology 2026 7. Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis. — Thorax 2026 8. Optimizing mask selection for obstructive sleep apnea treatment with CPAP. — Chest 2026 9. Added Value of Expiratory CT in Chronic Airflow Limitation. — Respiratory Medicine 2026 10. Antifungal Prophylaxis and Preemptive Therapy to Prevent COVID-19-Associated Pulmonary Aspergillosis in Patients Requiring Advanced Respiratory Support: A Real… — Respiratory Medicine 2026 Listen at https://audioscholar.cc/episode/6zkvrdu3t9

  2. Aug 4

    This Week in Pulmonary — Aug 4, 2026

    Welcome to This Week in Pulmonary. This week we are covering ten notable papers spanning innovations in acute care oxygenation and sepsis phenotypes, optimization strategies in chronic airway and interstitial diseases, and new insights into pulmonary… This week's papers: 1. Autonomous Oxygen Titration for Maintaining Normoxemia in Acutely Ill Adults: The SAVE-O2 AI Randomized Clinical Trial. — JAMA internal medicine 2026 2. Inhaled and oral corticosteroid use and the risk of pulmonary aspergillosis: a Danish population-based case-control study. — Thorax 2026 3. Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics. — American journal of respiratory and critical care medicine 2026 4. Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small C… — Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2026 5. Comorbid Insomnia is Associated with Enhanced Blood Pressure Reduction with CPAP Therapy in Patients with Obstructive Sleep Apnea: A Prospective Cohort Study. — Chest 2026 6. Effects of riociguat on right ventricular size and function in pulmonary arterial hypertension (RIVER II): a prospective, phase IV study. — Respiratory research 2026 7. De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study. — Respiratory medicine 2026 8. Impact of obstructive lung disease on survival in patients with rheumatoid arthritis related interstitial lung disease. — Respiratory medicine 2026 9. Severity-based evaluation of dynamic airway collapse and tracheobronchomalacia: integrated clinical, functional and bronchoscopic assessment with a diagnostic-… — Respiratory medicine 2026 10. Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis. — Respiratory medicine 2026 Listen at https://audioscholar.cc/episode/4crn8b9ue3

  3. Jul 31

    This Week in Pulmonary — Jul 31, 2026

    Welcome to This Week in Pulmonary. This week we're covering 10 notable papers spanning major advances in chronic airway disease management, diagnostic innovations in oncology and infections, and critical updates in pulmonary fibrosis and mechanical v… This week's papers: 1. Effect of nerandomilast on survival in patients with pulmonary fibrosis. — The European Respiratory Journal 2026 2. Effect of maintenance macrolide de-escalation during the Australian summer on exacerbations of obstructive airway diseases: a randomised, double-blind, placebo… — Thorax 2026 4. ERS/ESCMID state-of-the-science statement on the role of rapid diagnostic tests for the diagnosis and management of community-acquired lower respiratory tract… — The European Respiratory Journal 2026 5. Prognostic impact of single moderate exacerbation in COPD patients: Analysis of 12-year mortality and future exacerbation risk. — Chest 2026 6. Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants. — Chest 2026 7. Impact of Bronchiectasis on Treatment Outcomes in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A 10-Year Retrospective Cohort Study Stratified… — Chest 2026 8. Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes. — Respiratory Medicine 2026 9. Low levels of emphysema burden on LDCT and spirometry-based OLD: Joint Effects on Mortality. — Chest 2026 10. Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC. — Journal of Thoracic Oncology 2026 Listen at https://audioscholar.cc/episode/b96b5yqk8y

  4. Jul 21

    This Week in Pulmonary — Jul 21, 2026

    Welcome to This Week in Pulmonary. This week we're covering eight notable papers spanning advanced chronic obstructive pulmonary disease management, diagnostic and therapeutic advances in thoracic oncology, systemic infectious risks in pulmonary medi… This week's papers: 1. Comparative effectiveness of oral appliances and continuous positive airway pressure: a prospective non-randomized study using a non-inferiority framework. — American Journal of Respiratory and Critical Care Medicine 2026 2. Clinical Utility of Next Generation Sequencing in Concurrent EBUS-TBNA and Liquid Biopsies in NSCLC. — American Journal of Respiratory and Critical Care Medicine 2026 3. Impact of comorbidities on endobronchial valve treatment response in severe emphysema patients. — Respiratory Medicine 2026 4. Cancer risk in patients with nontuberculous mycobacterial pulmonary disease: a nationwide population-based cohort study. — Respiratory Research 2026 5. Pneumocystis jirovecii Pneumonia in Solid Tumors: High Mortality Amid Frequent Corticosteroid Exposure and Infrequent Prophylaxis. — Respiratory Medicine 2026 6. Immune checkpoint inhibitors were not associated with poor asthma control in patients with pre-existing asthma. — Respiratory Medicine 2026 7. Impact of High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease Exacerbation: A Systematic Review of Clinical and Physiological Outcomes. — International Journal of Chronic Obstructive Pulmonary Disease 2026 8. Smoking Cessation and Depression Risk in Newly Diagnosed COPD Patients: A Nationwide Cohort Study. — Respiratory Medicine 2026 Listen at https://audioscholar.cc/episode/g6tk5mcf39

  5. Jul 14

    This Week in Pulmonary — Jul 14, 2026

    Welcome to This Week in Pulmonary. This week we're covering eight notable papers spanning advanced diagnostics in pulmonary vascular disease, optimizing management in chronic airway diseases like chronic obstructive pulmonary disease and cystic fibro… This week's papers: 1. YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial — JAMA 2026 2. Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease — American Journal of Respiratory and Critical Care Medicine 2026 3. Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care — American Journal of Respiratory and Critical Care Medicine 2026 4. Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis — American Journal of Respiratory and Critical Care Medicine 2026 5. Multimodal model for predicting exercise-induced pulmonary hypertension validated by invasive exercise hemodynamics: a prospective study — Respiratory Research 2026 6. Timely management of COPD exacerbations is associated with limited acute deterioration and early recovery: a prospective observational study — Respiratory Research 2026 7. Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions — International Journal of Chronic Obstructive Pulmonary Disease 2026 8. Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research — American Journal of Respiratory and Critical Care Medicine 2026 Listen at https://audioscholar.cc/episode/rebuc2ahe4

  6. Jul 7

    This Week in Pulmonary — Jul 7, 2026

    Welcome to This Week in Pulmonary. This week we're covering 10 notable papers spanning advances in lung cancer screening and oncologic genetics, novel management strategies for chronic obstructive pulmonary disease and asthma, and critical insights i… This week's papers: 1. Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial. — Journal of Thoracic Oncology 2026 2. In acute hypoxemic respiratory failure, high-flow vs. standard oxygen therapy did not reduce mortality at 28 d. — Annals of Internal Medicine 2026 3. In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at =48 wk. — Annals of Internal Medicine 2026 4. Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical Trial. — JAMA Internal Medicine 2026 5. Eight-week high-intensity inspiratory muscle training improves cardiac autonomic function in COPD: a randomised controlled trial. — Respiratory Medicine 2026 6. Obesity and Early Sepsis-Associated Acute Respiratory Distress Syndrome: A Prospective Multicenter Study. — Respiratory Medicine 2026 7. Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion. — Chest 2026 8. In adults with COPD, the BLISS score predicted risk for acute respiratory hospital admission at 2 y. — Annals of Internal Medicine 2026 9. Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights from a Large-Scale Real-World Chinese Cohort. — Journal of Thoracic Oncology 2026 10. Germline Mutations as Risk Factors for Lung Cancer: A Systematic Review and Meta-analysis. — Journal of Thoracic Oncology 2026 Listen at https://audioscholar.cc/episode/3rmbh4wvhn

  7. Jun 22

    This Week in Pulmonary — Jun 22, 2026

    Welcome to This Week in Pulmonary. This week we are covering nine notable papers spanning chronic airway diseases and systemic intersections, advanced diagnostics and global health vulnerabilities, and clinical management frameworks. Let's dive in.… This week's papers: 1. Social and health factors associated with postmortem diagnosis of tuberculosis in England: a national, retrospective cohort study. — Thorax 2026 2. When does change become progression? Defining meaningful quantitative CT thresholds in Idiopathic Pulmonary Fibrosis. — American Journal of Respiratory and Critical Care Medicine 2026 3. Phenotyping of pulmonary arterial hypertension associated with congenital heart disease using latent class analysis: insights from a national prospective regis… — Chest 2026 4. Extracorporeal life support in adult critically ill patients: mechanisms of benefit in respiratory and cardiac failure. — American Journal of Respiratory and Critical Care Medicine 2026 5. Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study). — Respiratory Research 2026 6. PREVALENCE AND RISK FACTORS OF PRESERVED RATIO IMPAIRED SPIROMETRY (PRISm) IN PEOPLE WITH HIV AND MATCHED POPULATION CONTROLS. — Chest 2026 7. How I Do It: Counseling Patients About Outdoor Exercise During Air Pollution Events. — Chest 2026 8. IL-17 inhibitor therapy and risk of chronic obstructive pulmonary disease and related pulmonary outcomes in patients with psoriasis: A real-world cohort study. — Respiratory Medicine 2026 9. The UCL-Lancet Commission on Migration and Health: review of the state of progress. — Lancet 2026 10. Characteristics and management of asthma from the China Asthma Data Registry Project. — ERJ Open Research 2026 Listen at https://audioscholar.cc/episode/uxjjnm5udw

About

Pulmonary — a weekly podcast briefing of the most significant peer-reviewed pulmonary literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.